» Articles » PMID: 27403880

A Combination of an Iron Chelator with an Antioxidant Effectively Diminishes the Dendritic Loss, Tau-hyperphosphorylation, Amyloids-β Accumulation and Brain Mitochondrial Dynamic Disruption in Rats with Chronic Iron-overload

Overview
Journal Neuroscience
Specialty Neurology
Date 2016 Jul 13
PMID 27403880
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Iron-overload can cause cognitive impairment due to blood-brain barrier (BBB) breakdown and brain mitochondrial dysfunction. Although deferiprone (DFP) has been shown to exert neuroprotection, the head-to-head comparison among iron chelators used clinically on brain iron-overload has not been investigated. Moreover, since antioxidant has been shown to be beneficial in iron-overload condition, its combined effect with iron chelator has not been tested. Therefore, the hypothesis is that all chelators provide neuroprotection under iron-overload condition, and that a combination of an iron chelator with an antioxidant has greater efficacy than monotherapy. Male Wistar rats (n=42) were assigned to receive a normal diet (ND) or a high-iron diet (HFe) for 4months. At the 2nd month, HFe-fed rats were treated with a vehicle, deferoxamine (DFO), DFP, deferasirox (DFX), n-acetyl cysteine (NAC) or a combination of DFP with NAC, while ND-fed rats received vehicle. At the end of the experiment, rats were decapitated and brains were removed to determine brain iron level and deposition, brain mitochondrial function, BBB protein expression, brain mitochondrial dynamic, brain apoptosis, tau-hyperphosphorylation, amyloid-β (Aβ) accumulation and dendritic spine density. The results showed that iron-overload induced BBB breakdown, brain iron accumulation, brain mitochondrial dysfunction, impaired brain mitochondrial dynamics, tau-hyperphosphorylation, Aβ accumulation and dendritic spine reduction. All treatments, except DFX, attenuated these impairments. Moreover, combined therapy provided a greater efficacy than monotherapy. These findings suggested that iron-overload induced brain iron toxicity and a combination of an iron chelator with an antioxidant provided a greatest efficacy for neuroprotection than monotherapy.

Citing Articles

From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.

Sighencea M, Popescu R, Trifu S Int J Mol Sci. 2024; 25(22).

PMID: 39596378 PMC: 11594972. DOI: 10.3390/ijms252212311.


Exploring alterations of gut/blood microbes in addressing iron overload-induced gut dysbiosis and cognitive impairment in thalassemia patients.

Suparan K, Trirattanapa K, Piriyakhuntorn P, Sriwichaiin S, Thonusin C, Nawara W Sci Rep. 2024; 14(1):24951.

PMID: 39438708 PMC: 11496663. DOI: 10.1038/s41598-024-76684-4.


Iron Reduces the Trafficking of Fatty Acids from Human Immortalised Brain Microvascular Endothelial Cells Through Modulation of Fatty Acid Transport Protein 1 (FATP1/SLC27A1).

Supti S, Koehn L, Newman S, Pan Y, Nicolazzo J Pharm Res. 2024; 41(8):1631-1648.

PMID: 39044044 PMC: 11362236. DOI: 10.1007/s11095-024-03743-w.


Mechanistic elucidation of ferroptosis and ferritinophagy: implications for advancing our understanding of arthritis.

Guo C, Peng J, Cheng P, Yang C, Gong S, Zhang L Front Physiol. 2024; 15:1290234.

PMID: 39022306 PMC: 11251907. DOI: 10.3389/fphys.2024.1290234.


Hesperidin Attenuates Titanium Dioxide Nanoparticle-Induced Neurotoxicity in Rats by Regulating Nrf-2/TNF-α Signaling Pathway, the Suppression of Oxidative Stress, and Inflammation.

Eid A, Ghaleb S, Zaki A, Ibrahim M, Farghali A, Ali L ACS Omega. 2023; 8(40):37584-37591.

PMID: 37841165 PMC: 10568688. DOI: 10.1021/acsomega.3c06198.